Association between the polymorphism of TGF-beta1 gene promoter (-509C>T) and idiopathic chronic urticaria

Iran J Allergy Asthma Immunol. 2006 Sep;5(3):109-13.

Abstract

Idiopathic Chronic Urticaria (ICU), the most common form (70-80%) of chronic urticaria is supposed to have immune basis causes. It is speculated that the promoter polymorphism of TGF-Beta1 gene may be involved in ICU. This condition is thought to affect at least 0.1% of the population and often can be severe and difficult to treat. A total of 40 patients with ICU and 41 normal subjects were studied. DNA was extracted from whole blood and TGF-Beta1 promoter -509C>T polymorphism was determined by PCR-RFLP method. Out of the 40 patients with ICU, 11 (27.5%) had CC, 26 (65%) had CT and 3 (7.5%) had TT genotypes. A higher proportion of case subjects with the C allele (CT type or CC type) was found compared with the T allele. These results do suggest an influence of genetic variability at the promoter of TGF-Beta1 gene (-509C>T) on the occurrence of ICU. This polymorphism has been shown as a useful genetic change in our study. Further work is required to confirm this result.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Case-Control Studies
  • Female
  • Humans
  • Iran / epidemiology
  • Male
  • Polymorphism, Single Nucleotide
  • Promoter Regions, Genetic
  • Transforming Growth Factor beta1 / genetics*
  • Urticaria / epidemiology
  • Urticaria / genetics*

Substances

  • Transforming Growth Factor beta1